Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced Clinical trial data shows RAD 101 detects Brain Metastases Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Torchlight Innovations Inc.Opens the Market October 25, 2025 Thor Energy Plans to Recover Uranium, Critical Minerals from Colorado Mine Waste October 25, 2025 Quimbaya Gold Announces Upsize of Bought Deal Financing to $12.5 Million October 25, 2025